Changes in HCV viremia following LDL apheresis in a HCV positive patient with familial hypercholesterolemia

Int J Artif Organs. 1999 Sep;22(9):640-4.

Abstract

It has been suggested that hepatitis C virus (HCV) can be associated with beta-lipoprotein in human serum. According to this, the LDL receptor could promote endocytosis of such a virus. In the present study, we evaluated the changes in HCV viremia in a HCV positive patient with familial hypercholesterolemia, undergoing both selective (DALI System, Fresenius) and non-selective (plasma exchange) LDL apheresis. HCV-RNA levels did not decrease following selective LDL apheresis, on the contrary showed a random, odd variation pattern (from -35% to +72%). Conversely, plasma exchange steadily induced a drop in HCV viremia (-35/43%), to a lower extent than that of a totally intravascular plasmaprotein, i.e., alpha 2-macroglobulin (-53/54%). These data indicate that beta-lipoprotein may not function as a plasma carrier of HCV, at least in the present case. Moreover, a continuous, quantitatively unforeseeable circulation of HCV virions from the intravascular plasma compartment to other extravascular and intracellular sites, seems to occur during an apheresis session.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Cholesterol / blood
  • Hepacivirus / isolation & purification*
  • Hepatitis C / complications
  • Hepatitis C / diagnosis
  • Hepatitis C / virology*
  • Humans
  • Hyperlipoproteinemia Type II / complications*
  • Hyperlipoproteinemia Type II / diagnosis
  • Hyperlipoproteinemia Type II / therapy*
  • Lipoproteins, LDL / blood*
  • Male
  • Plasmapheresis / methods*
  • RNA, Viral / analysis
  • Treatment Outcome
  • Viral Load
  • Viremia / complications
  • Viremia / diagnosis
  • Viremia / virology*

Substances

  • Lipoproteins, LDL
  • RNA, Viral
  • Cholesterol